Valuation: SpineGuard

Market Cap 7.91M 9.02M 7.29M 6.82M 12.79M 851M 13.06M 87.59M 33.89M 420M 33.86M 33.12M 1.46B P/E 2024
-3.63x
P/E 2025 -3.37x
Enterprise Value 7.64M 8.71M 7.04M 6.59M 12.36M 822M 12.62M 84.65M 32.75M 406M 32.72M 32.01M 1.41B EV / Sales 2024
2.94x
EV / Sales 2025 2.33x
Free-Float
97.68%
Yield 2024 *
-
Yield 2025 -
1 day-0.83%
1 week-7.22%
Current month-12.11%
1 month-15.57%
3 months-29.36%
6 months-14.36%
Current year-17.33%
1 week 0.08
Extreme 0.0811
0.09
1 month 0.08
Extreme 0.0811
0.1
Current year 0.08
Extreme 0.0811
0.14
1 year 0.08
Extreme 0.0755
0.3
3 years 0.08
Extreme 0.0755
0.66
5 years 0.08
Extreme 0.0755
1.77
10 years 0.08
Extreme 0.0755
5.49
Manager TitleAgeSince
Chief Executive Officer - 15/02/2020
Director of Finance/CFO - 01/01/2009
Chief Tech/Sci/R&D Officer - 01/09/2019
Director TitleAgeSince
Director/Board Member - 16/01/2009
Director/Board Member - 02/07/2009
Chairman - 01/03/2018
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-7.22%-18.46%-78.20% 9M
+0.26%+0.65%+25.50%-3.34% 12.48B
+2.84%+4.96%+61.12%+32.89% 5.95B
-1.15%+2.49%+7.16%+8.90% 5.61B
-2.81%-0.60% - - 3.99B
-3.75%-5.41%-37.85%+8.18% 3.91B
-1.95%+3.48%-28.15%-26.32% 3.83B
-0.97%-3.62%+50.61%+247.90% 1.81B
+0.76%+11.54%-11.23%-63.42% 1.74B
0.00%+0.37%+58.74%-6.01% 1.54B
Average -0.73%-0.13%+11.94%+13.40% 4.09B
Weighted average by Cap. -0.45%+0.33%+17.03%+12.53%

Financials

2024 2025
Net sales 4.65M 5.3M 4.28M 4.01M 7.52M 500M 7.68M 51.5M 19.93M 247M 19.91M 19.47M 857M 3.76M 4.29M 3.46M 3.24M 6.08M 404M 6.21M 41.63M 16.11M 200M 16.09M 15.74M 693M
Net income -3.08M -3.51M -2.84M -2.66M -4.99M -332M -5.09M -34.14M -13.21M -164M -13.2M -12.91M -568M -2.07M -2.36M -1.91M -1.78M -3.35M -222M -3.42M -22.91M -8.86M -110M -8.85M -8.66M -381M
Net Debt 1.82M 2.07M 1.68M 1.57M 2.94M 196M 3M 20.15M 7.8M 96.7M 7.79M 7.62M 335M -265K -303K -245K -229K -429K -28.55M -438K -2.94M -1.14M -14.11M -1.14M -1.11M -48.93M
Logo SpineGuard
SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.
Employees
13
Date Price Change Volume
26/06/26 0.0835 -0.83% 207,480
25/06/26 €0.0842 -0.94% 808,558
24/06/26 €0.0850 -2.30% 118,418
23/06/26 €0.0870 -2.79% 175,661
22/06/26 €0.0895 -0.56% 115,466
  1. Stock Market
  2. Stocks
  3. ALSGD Stock